Not all anti‐ CD38 antibodies are created equal: The epitope of felzartamab is partially DTT ‐resistant - Anja Zeretzke; Philipp Trummer; Cora P. Habicht; Clemens Schneeweiss (Transfusion Medicine, 2026)